Medtronic (MDT)

Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs.

In a welcome move, Medtronic stock saw its Relative Strength Rating improve to 73 on Tuesday, up form 67 a day earlier.

The medical device maker has been a huge winner for its long-term shareholders.

China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, with Vice Premier He Lifeng promising a better business environment amid rising U.S. tariff pressures and slowing foreign investment.

Balancing Dividends and Fundamentals: The Case of MEDTRONIC PLC (NYSE:MDT).

MEDTRONIC PLC (NYSE:MDT) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:MDT Could Be on the Verge of a Breakout. Here's What You Need to Know.

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.

Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news

Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.

The company said its medical-surgical segment struggled with ongoing stapling market pressures and temporary shifts in U.S. distributor buying patterns.

MDT earnings call for the period ending December 31, 2024.

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.